Development partners

BioMotiv, the for-profit accelerator of The Harrington Project, is the developer and lead funder of Nynex Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.

Learn more about BioMotiv here

becoming a partner

We are open to partnering with other organizations. Please reach out to us via the form below if you or your company are interested in partnering with Nynex Therapeutics.

Name *